Research by Park J R and colleagues found that Huangqin extract (SBGE) acts on MCF-7 breast cancer cells, increasing the sub-G1 phase ratio, inhibiting mitochondrial membrane potential, and inducing cell apoptosis by downregulating Bcl-2 and upregulating Bax. This evidence concerns the gene BCL2 and breast carcinoma.